Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2011

Open Access 01-12-2011 | Research article

Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma

Authors: Masahiro Yokouchi, Mikio Terahara, Satoshi Nagano, Yoshiya Arishima, Michihisa Zemmyo, Takako Yoshioka, Akihide Tanimoto, Setsuro Komiya

Published in: BMC Musculoskeletal Disorders | Issue 1/2011

Login to get access

Abstract

Background

To determine safe surgical margins for soft tissue sarcoma, it is essential to perform a general evaluation of the extent of tumor, responses to auxiliary therapy, and other factors preoperatively using multiple types of diagnostic imaging. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is a tool for diagnostic imaging that has recently spread rapidly in clinical use. At present, the roles played by FDG-PET/CT in determination of margins for surgical resection of sarcoma are unclear. The present study was undertaken to explore the roles of FDG-PET/CT in determination of surgical margins for soft tissue sarcoma and to examine whether PET can serve as a standard means for setting the margins of surgical resection during reduced surgery.

Methods

The study involved 7 patients with sarcoma who underwent surgery in our department and in whom evaluation with FDG-PET/CT was possible. Sarcoma was histologically rated as MFH in 6 cases and leiomyosarcoma in 1 case. In all cases, sarcoma was superficial (T1a or T2a). The tumor border was defined by contrast-enhanced MRI, and SUVs were measured at intervals of 1 cm over a 5-cm long area from the tumor border. Mapping of viable tumor cells was carried out on whole-mount sections of resected tissue, and SUVs were compared with histopathological findings.

Results

Preoperative maximum SUVs (SUV-max) of the tumor averaged 11.7 (range: 3.8-22.1). Mean SUV-max was 2.2 (range: 0.3-3.8) at 1 cm from the tumor border, 1.1 (0.85-1.47) at 2 cm, 0.83 (0.65-1.15) at 3 cm, 0.7 (0.42-0.95) at 4 cm, and 0.64 (0.45-0.82) at 5 cm. When resected tissue was mapped, tumor cells were absent in the areas where SUV-max was below 1.0.

Conclusions

Our findings suggest that a safe surgical margin free of viable tumor cells can be ensured if the SUV cut-off level is set at 1.0. FDG-PET/CT is promising as a diagnostic imaging technique for setting of safe minimal margins for surgical resection of soft tissue sarcoma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Enneking WF, Spanier SS, Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop. 1980, 153: 106-120.PubMed Enneking WF, Spanier SS, Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop. 1980, 153: 106-120.PubMed
2.
go back to reference Kawaguchi N: Curative limb saving operation (curative wide resection). Gan To Kagaku Ryoho. 1984, 11 (9): 1736-45.PubMed Kawaguchi N: Curative limb saving operation (curative wide resection). Gan To Kagaku Ryoho. 1984, 11 (9): 1736-45.PubMed
3.
go back to reference Folpe AL, Lyles RH, Sprouse JT, Conrad EU, Eary JF: (F-18)fluorodeoxyglucose position emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res. 2000, 6: 1279-1287.PubMed Folpe AL, Lyles RH, Sprouse JT, Conrad EU, Eary JF: (F-18)fluorodeoxyglucose position emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res. 2000, 6: 1279-1287.PubMed
4.
go back to reference Zheng XK, Chen LH, Wang QS, Wu HB, Wang HM, Chen YQ, Yan WP, Li QS, Xu YK: Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007, 69 (5): 1381-1388. 10.1016/j.ijrobp.2007.05.033.CrossRefPubMed Zheng XK, Chen LH, Wang QS, Wu HB, Wang HM, Chen YQ, Yan WP, Li QS, Xu YK: Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007, 69 (5): 1381-1388. 10.1016/j.ijrobp.2007.05.033.CrossRefPubMed
5.
go back to reference Ford EC, Herman J, Yorke E, Wahl RL: 18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy. J Nucl Med. 2009, 50: 1655-1665. 10.2967/jnumed.108.055780.CrossRefPubMedPubMedCentral Ford EC, Herman J, Yorke E, Wahl RL: 18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy. J Nucl Med. 2009, 50: 1655-1665. 10.2967/jnumed.108.055780.CrossRefPubMedPubMedCentral
6.
go back to reference Kawaguchi N, Matumoto S, Manabe J: New method of evaluating the surgical margin and safety margin for musculoskeletal sarcoma, analyzed on the basis of 457 surgical cases. J Cancer Res Clin Oncol. 1995, 121: 555-563. 10.1007/BF01197769.CrossRefPubMed Kawaguchi N, Matumoto S, Manabe J: New method of evaluating the surgical margin and safety margin for musculoskeletal sarcoma, analyzed on the basis of 457 surgical cases. J Cancer Res Clin Oncol. 1995, 121: 555-563. 10.1007/BF01197769.CrossRefPubMed
7.
go back to reference Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y: The Concept of Curative Margin in Surgery for Bone and Soft Tissue Sarcoma. Clin Orthop. 2004, 419: 165-172.CrossRefPubMed Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y: The Concept of Curative Margin in Surgery for Bone and Soft Tissue Sarcoma. Clin Orthop. 2004, 419: 165-172.CrossRefPubMed
8.
go back to reference Sarcoma Meta-analysis Collaboration: Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet. 1997, 350: 1647-54.CrossRef Sarcoma Meta-analysis Collaboration: Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet. 1997, 350: 1647-54.CrossRef
9.
go back to reference Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM, Merino MJ, Rosenberg SA: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. Journal of Clinical Oncology. 1998, 16: 197-203.PubMed Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM, Merino MJ, Rosenberg SA: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. Journal of Clinical Oncology. 1998, 16: 197-203.PubMed
10.
go back to reference DeLaney TF, Park L, Goldberg SI, Hug EB, Liebsch NJ, Munzenrider JE, Suit HD: Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys. 2005, 61: 492-498. 10.1016/j.ijrobp.2004.05.051.CrossRefPubMed DeLaney TF, Park L, Goldberg SI, Hug EB, Liebsch NJ, Munzenrider JE, Suit HD: Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys. 2005, 61: 492-498. 10.1016/j.ijrobp.2004.05.051.CrossRefPubMed
11.
go back to reference Davidge KM, Wunder J, Tomlinson G, Wong R, Lipa J, Davis AM: Function and Health Status Outcomes Following Soft Tissue Reconstruction for Limb Preservation in Extremity Soft Tissue Sarcoma. Ann Surg Oncol. 2010, 17: 1052-1062. 10.1245/s10434-010-0915-5.CrossRefPubMed Davidge KM, Wunder J, Tomlinson G, Wong R, Lipa J, Davis AM: Function and Health Status Outcomes Following Soft Tissue Reconstruction for Limb Preservation in Extremity Soft Tissue Sarcoma. Ann Surg Oncol. 2010, 17: 1052-1062. 10.1245/s10434-010-0915-5.CrossRefPubMed
12.
go back to reference Nelson AA, Frassica FJ, Gordon TA, Deune EG: Cost Analysis of Functional Restorarion Surgery for Extremity Soft-Tissue Sarcoma. Plast Reconstr Surg. 2006, 117 (1): 277-83. 10.1097/01.prs.0000187140.83705.cf.CrossRefPubMed Nelson AA, Frassica FJ, Gordon TA, Deune EG: Cost Analysis of Functional Restorarion Surgery for Extremity Soft-Tissue Sarcoma. Plast Reconstr Surg. 2006, 117 (1): 277-83. 10.1097/01.prs.0000187140.83705.cf.CrossRefPubMed
13.
go back to reference Gondi V, Bradley K, Mehta M, Howard A, Khuntia D, Ritter M, Tomé W: Impact of hybrid fluorodeoxyglucose position-emission tomography/computed tomography on radiotherapy planniing in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007, 1:67 (1): 187-195.CrossRefPubMed Gondi V, Bradley K, Mehta M, Howard A, Khuntia D, Ritter M, Tomé W: Impact of hybrid fluorodeoxyglucose position-emission tomography/computed tomography on radiotherapy planniing in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007, 1:67 (1): 187-195.CrossRefPubMed
14.
go back to reference race P, D'Ambrosio D, Merigo F, Galiè M, Nanni C, Spinelli A, Fanti S, Degrassi A, Sbarbati A, Rubello D, Marzola P: Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET dilineation of radiotherapy target. Eur J Nucl Med Mol Imaging. 2009, 36 (4): 616-623. 10.1007/s00259-008-1012-x.CrossRef race P, D'Ambrosio D, Merigo F, Galiè M, Nanni C, Spinelli A, Fanti S, Degrassi A, Sbarbati A, Rubello D, Marzola P: Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET dilineation of radiotherapy target. Eur J Nucl Med Mol Imaging. 2009, 36 (4): 616-623. 10.1007/s00259-008-1012-x.CrossRef
Metadata
Title
Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma
Authors
Masahiro Yokouchi
Mikio Terahara
Satoshi Nagano
Yoshiya Arishima
Michihisa Zemmyo
Takako Yoshioka
Akihide Tanimoto
Setsuro Komiya
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2011
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-12-166

Other articles of this Issue 1/2011

BMC Musculoskeletal Disorders 1/2011 Go to the issue